Angiogenesis inhibitors: from laboratory to clinical application.
Nakamura
Toshikazu
T
Division of Molecular Regenerative Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan. nakamura@onbich.med.osaka-u.ac.jp
Matsumoto
Kunio
K
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000818:Animals; D006801:Humans; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy* / Q000276:immunology; D009389:Neovascularization, Pathologic / Q000276:immunology* / Q000517:prevention & control*; D018919:Neovascularization, Physiologic / Q000187:drug effects* / Q000276:immunology*; D042442:Vascular Endothelial Growth Factors / Q000276:immunology
D020533:Angiogenesis Inhibitors; D042442:Vascular Endothelial Growth Factors